NDRA Earnings

Quarterly EPS
$-9.54
Q3 2024
$0.00
Q4 2024
$-1.86
Q1 2025
$-1.71
Q2 2025
$-2.10
Q3 2025
$-2.85
Q4 2025
$-1.09
Q1 2026
$0.12
Q2 2026
Latest RevenueN/A
Latest Net Income159.9K
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.120159.9K—+107.0%
Q1 2026-$1.090-1311433—+41.4%
Q4 2025-$2.850-3169209——
Q3 2025-$2.100-1595959—+78.0%
Q2 2025-$1.710-1225912—-2,037.5%
Q1 2025-$1.860-1036330—+99.6%
Q4 2024—0-4149004——
Q3 2024-$9.540-2354090—+98.6%
Q2 2024-$0.080-2229153——
Q1 2024-$449.580-2775700——
Q4 2023-$156.840-1459536——
Q3 2023-$706.200-3100836——
ENDRA Life Sciences (NDRA) — Earnings